Councils - Mechanical Circulatory Support

Scientific Council on Mechanical Circulatory Support


Council membership is open to all ISHLT members. Joining is easy. Simply login to the ISHLT Members Only Website where you can update your membership profile and join any of the 11 Scientific Councils.

Friday, April 17, 2015, 12:30 PM - 1:30 PM
Acropolis Congres Centre, Nice, FRANCE


Masters Course 2 in Mechanical Circulatory Support
Tuesday, April 14, 2015

Visit for more details.



The ISHLT is pleased to announce the ISHLT/HeartWare Award for Translational Research in MCS. Click HERE for details.


2014 MCS Council Report to Board (PDF)


•  Core Competencies in Mechanical Circulatory Support
•  Masters Course in Mechanical Circulatory Support

Monday & Tuesday, April 7-8, 2014
Coronado, CA, USA


Thank you to all of the members who reviewed and submitted comments on the posted guidelines. These guidelines have now been published and are available at


Issues focusing on MCS:

August 2014
January 2014
July 2013
May 2013: MCS Council Year in Review
March 2013
October 2011 (PDF)


Order your copy of Monograph Volume 1: Mechanical Circulatory Support - click HERE for details.

Council Leadership Operating Board:


Ulrich P. Jorde, MD (2017)
Montefiore Medical Center
Albert Einstein College of Medicine
Bronx, NY, USA

Dr. Jorde graduated from the Freie Universitaet Hamburg Medical School, Germany in 1991 and subsequently completed clinical training in Internal Medicine and Cardiology at Mount Sinai School of Medicine and the Albert Einstein College of Medicine, both New York. He then joined the heart failure and transplant faculty of the Center for Advanced Care at Columbia University in 1999. From 2003 - 2007, he directed the heart failure program at New York University. He returned to Columbia University in 2007 as medical director of one of the nation’s largest mechanical circulatory support programs. He is currently Associate Professor of Medicine with continuous research funding from the National Institutes of Health and American Heart Association and has published over 80 manuscripts in peer-reviewed journals. He has mentored several junior faculty members at Columbia University, one of whom was recently awarded the most prestigious NIH mentored career award (K23).


Prof Stephan Schueler, MD, PhD, FRCS (2019)
Newcastle Upon Tyne Hospital
Freeman Hospital
Newcastle Upon Tyne, UNITED KINGDOM

Bio coming soon...


Nir Uriel, MD (2021)
University of Chicago
Chicago, IL, USA

Bio coming soon...


Daniel J. Goldstein, MD (2015)
Montefiore Medical Center
Bronx, New York, USA

Dr. Daniel J. Goldstein is a Professor at the Albert Einstein College of Medicine and Vice Chairman of the Department of Cardiothoracic Surgery at Montefiore Medical Center in New York where he also serves as the Director of the Mechanical Assistance Program. He is a graduate of the Mount Sinai School of Medicine (1991) and completed his general surgery and cardiothoracic surgery training at Columbia Presbyterian Medical Center in New York in 2000. While clinically active in all aspects of adult cardiothoracic surgery including coronary, valvular and aneurysmal heart disease, his clinical and research interests focus on the surgical management of end stage heart disease including stem cell therapies and pharmacological adjuncts for induction of left ventricular recovery in patients supported with left ventricular assist devices. Dr. Goldstein is an active member of the INTERMACS adverse event committee and has partaken as principal site investigator in multiple industry-based and NIH-supported clinical ventricular assist device trials.


Francis D. Pagani, MD, PhD (2015)
University of Michigan Hospital
Ann Arbor, Michigan, USA

Francis D. Pagani, MD, PhD, is the Surgical Director of the Adult Heart Transplant Program and Director of the Center for Circulatory Support at the University of Michigan in Ann Arbor, Michigan. The Center for Circulatory Support (VAD Program), under Dr. Pagani's direction, is one of the most recognized and well-respected programs in the nation. His clinical interests include adult cardiac surgery with emphases on Heart Transplantation, Tricuspid Valve Disease, Aortic Valve Disease, Mitral Valve Disease, Coronary Artery Disease, Hypertrophic Cardiomyopathy/ Myectomies, Heart Failure and Mechanical Circulatory Support Systems. Dr. Pagani received his medical degree from Georgetown University School of Medicine in Washington, DC. After completing his internship, surgery residency at Georgetown University Hospital, he completed a cardiovascular surgery research fellowship at the University of Massachusetts Medical Center in Worcester, MA. He then went on to complete another surgical residency at Georgetown University Hospital and a thoracic surgical residency at the University of Michigan Medical Center.

Martin Strueber, MD (2015)
Richard DeVos Heart & Lung Transplant Program
Spectrum Health Hospital
Grand Rapids, MI, USA

Dr. Strueber was trained as a cardiothoracic surgeon in Hannover and Kiel, Germany and became a staff surgeon at Hannover Medical School Cardiothoracic Program.  In 1998, he became the Surgical Director of their Heart and Lung Transplant Program. Shortly thereafter, a VAD program was started.  In addition to these programs, Dr. Strueber was also directing a translational research program in lung transplantation and mechanical circulatory support.  In 2012, he took a position as the Surgical Director of Heart and Lung Transplant as well as the MCS program at the University Heart Center in Leipzig, Germany, one of the largest heart centers in Europe.  At the same time, he joined the Board of Directors of the International Society for Heart and Lung Transplantation. In January 2013, he was elected as President of the European Society for Heart and Lung Transplantation and in October 2014 he started as Surgical Director for Heart and Lung Transplantation, Heart Failure Surgery and MCS at Fred & Lena Meijer Heart and Vascular Institute, Richard DeVos Heart & Lung Transplant Services in Grand Rapids, Michigan.

Jeffrey J. Teuteberg, MD (2017)
University of Pittsburgh/Presbyterian
Pittsburgh, Pennsylvania, USA

Jeffrey Teuteberg, MD, is an Assistant Professor of Medicine, Associate Director of the Cardiac Transplant Program, and a member of the Heart Failure/Cardiac Transplant section of the McGowan Institute for Regenerative Medicine at the University of Pittsburgh Medical Center, where he specializes in the care of patients with advanced cardiomyopathies, cardiac transplantation, ventricular assist devices and pulmonary hypertension. He has particular interests in advanced heart failure and the transition to cardiac transplantation and ventricular assist devices. Dr. Teuteberg graduated from the University of Chicago, Pritzker School of Medicine, in 1992 and remained at the University of Chicago for his Internal Medicine Residency and general Cardiovascular Fellowship, during which he spent a year as the Chief Medical Resident. Dr. Teuteberg received his Heart Failure and Cardiac Transplant training at Brigham and Women's hospital in Boston.


Education Committee Representative

Salpy V. Pamboukian, MD, MSPH (2016)
University of Alabama at Birmingham
Birmingham, Alabama, USA

Dr. Pamboukian completed her MD degree at the University of Toronto, Canada, where she also completed an internal medicine residency. She received a cardiology fellowship at the University of British Columbia, Vancouver, followed by a cardiac transplantation and heart failure fellowship at Rush-Presbyterian — St. Luke’s Medical Center in Chicago, Illinois. Presently, she is Medical Director of the Mechanical Circulatory Support Device Program and co-section head of the Section of Advanced Heart Failure, Cardiac Transplant, Mechanical Circulatory Support and Pulmonary Vascular Disease at the University of Alabama at Bimingham.

I2C2 Committee Representative

Sean P. Pinney, MD (2017)
Mount Sinai Medical Center
New York, New York, USA

Bio coming soon...

Standards and Guidelines Committee Representative

David S. Feldman, MD, PhD, FACC, FAHA (2015)
Minneapolis Heart Institute
Minneapolis, Minnesota, USA

David S. Feldman, MD, PhD, FACC, FAHA, is a researcher and clinical cardiologist at the Minneapolis Heart Institute Foundation in Minneapolis, Minnesota. His interests include heart and lung transplantation. Dr. Feldman is also Director of Heart Failure, VAD and Cardiac Transplantation at the Minneapolis Heart Institute at Abbott Northwestern Hospital. Dr. Feldman received his medical training at the Medical College of Georgia in Atlanta. He completed his residency and a Medicine and Cardiology fellowship at Washington University School of Medicine in St. Louis, and a Molecular and Cell Biology fellowship at Duke University Medical Center in Durham, North Carolina.


Registries and Databases Committee Representative

Vivek Rao, MD, PhD
Toronto General Hospital
Toronto, Ontario, CANADA

Dr. Vivek Rao is the Chief of Cardiovascular Surgery and Professor of Surgery at the Toronto General Hospital where he is the Surgical Director of the Heart Transplant program. Dr. Rao completed his medical and surgical training at the University of Toronto prior to completing a fellowship in cardiac transplantation and mechanical circulatory support at New York’s Columbia-Presbyterian Hospital. In addition to performing a wide variety of cardiac surgical procedures, Dr. Rao is a recognized expert in heart failure surgery. He currently holds the Munk Chair in Advanced Cardiac Therapeutics at the Peter Munk Cardiac Center, Toronto General Hospital. In 2006, he was named as one of Canada’s “Top 40 under 40” by Caldwell Partners International.

ISHLT Links Newsletter Liaison

Evgenij V. Potapov, MD
German Heart Institute

Bio coming soon...

VAD Coordinator Liaison

Dawn M. Christensen, MS, CRNP
Innovative Program Solutions
Pine Grove, Pennsylvania, USA

Dawn Christensen, MS, FNP-BC, ACNP-BC is a nurse practitioner and owner of Innovative Program Solutions, LLC.  She received her nursing degrees from Temple University, Philadelphia in 1992 and Pennsylvania State University in 1997.  She began her career in the ICU at Penn State Hershey Medical Center caring for Adult and Pediatric Cardiothoracic Surgery patients.  She became the first Circulatory Support Coordinator at that institution in 1997 and in the eleven years at that position coordinated and conducted numerous training courses for outside institutions, participated in multiple clinical trials, and managed all aspects of the MCS program.  Since starting her own consulting company, she has had the opportunity to consult for multiple manufacturers as well as help institutions start new programs and prepare for regulatory review.  For the past three years she  has also served as the operations manager for MyLVAD. As one of the founding members of the ICCAC, and past president, she continues to promote the role of the VAD coordinator and remains active internationally within the group.


Basic Science and Translational Research Council Liaison

J. Michael DiMaio, MD
Baylor University Medical Center
Dallas, TX, USA

Bio coming soon...

Junior Faculty and Trainees Council Liaison

Palak Shah, MD, MS
Inova Fairfax Hospital
Falls Church, Virginia, USA

Palak Shah, MD, MS is a researcher and transplant Cardiologist at Inova Fairfax Hospital.  Dr. Shah’s clinical interests include advanced cardiomyopathies, mechanical circulatory support and cardiac transplantation.  He received his undergraduate training from Carnegie Mellon University and medical degree from St. George’s University in 2005.  He subsequently completed residency in Internal Medicine at Georgetown University.  In 2009, he spent a year as Chief Medical Resident at Georgetown University. During his Cardiovascular Disease Fellowship at George Washington University he received a Masters in Clinical and Translational Research and was also elected into the Alpha Omega Alpha honors society.  Dr. Shah received his Heart Failure and Cardiac Transplant training at the University of Michigan in 2012.  His research interests are focused in mechanical circulatory support; more specifically use of genomic tools to better predict and manage the complications of VAD therapy.

Text SizeIncrease Font SizeDecrease Font Size